Focal segmental glomerulosclerosis

Pediatric Nephrology

Volumn 10, Issue 3, 1996, Pages 374-391

  Ichikawa, Iekuni ^a   Fogo, Agnes ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Focal segmental glomerulosclerosis; Nephrotic syndrome; Progression; Proteinuria; Renal transplantation

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STEROID;

CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DETERIORATION; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REMISSION;

EID: 0029953347     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00866790     Document Type: Conference Paper

References (233)

1. Rennke HG, Klein PS (1989) Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13:443-456
2. Corwin HL, Schwartz MM, Lewis EJ (1988) The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 8:85-89
3. Remuzzi A, Mazarska M, Gephardt GN, Novick AC, Brenner BM, Remuzzi G (1995) Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int 48:155-162
4. Fogo A, Glick AD, Horn SL, Horn RG (1995) Is focal segmental glomerulosclerosis really focal? Distribution of lesions in adults and children. Kidney Int 47:1690-1696
5. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell Jr, Ichifcawa I (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 38:115-123
6. Schwartz MM, Korbet SM (1993) Primary focal segmental glomerulosclerosis: pathology, histological variants, and pathogenesis. Am J Kidney Dis 22:874-883
7. D'Agati V (1994) The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241
8. Sandison A, Newbold KM, Howie AJ (1992) Evidence for unique distribution of Kimmelstiel-Wilson nodules in glomeruli. Diabetes 41:952-955
9. Cohen AH, Nast CC (1988) HIV-associated nephropathy: a unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1:87-97
10. Detwiler RK, Falk RF, Hogan SL, Jennette JC (1994) Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424
11. Yoshikawa N, Itto H, Akamatsu R, Matsuyama S, Hasegawa O, Nakahara C, Matsu T (1986) Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J Pediatr 109:65-70
12. Ito H, Yoshikawa N, Aozai F, Hazikano H, Sakaguchi H, Akamatsu R, Matsuo T, Matsuyama S (1984) Twenty-seven children with focal segmental glomerulosclerosis: correlation between the segmentai location of the glomerular lesions and prognosis. Clin Nephrol 22:9-14
13. Howie AJ (1986) Changes at the glomerular tip: a feature of membranous nephropathy and other disorders associated with proteinuria. J Pathol 150:13-20
14. Howie AJ, Brewer DB (1985) Further studies on the glomerular tip lesion: early and late stages and life table analysis. J Pathol 147:245-255
15. Haas M, Spargo B, Coventry S (1995) Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 26:740-750
16. Schwartz MM, Lewis EJ (1985) Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int 28:968-974
17. Report of the Southwest Pediatric Nephrology Group (1983) Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. Kidney Int 24:87-94
18. International Study of Kidney Disease in Children (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 20:765-771
19. Hui A, Poucell S, Thorner P, Ranee CP, Baumal R (1984) Clinical features and glomerular immunofluorescence of renal biopsies from children with nephrotic syndrome due to minimal change disease and two variants of mesangial proliferative glomerulonephritis. Int J Pediatr Nephrol 5:5-10
20. Southwest Pediatric Nephrology Study Group (1985) A report: focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 27:442-449
21. Cohen AH, Border WA, Glassock R, Trysgtad C (1978) Glomerulonephritis with mesangial IgM deposits. Lab Invest 38:610-619
22. Tejani A, Nicastri AD (1983) Mesangial IgM nephropathy. Nephron 35:1-5
23. Saha H, Mustonen J, Pasternack A, Helin H (1989) Clinical follow-up of 54 patients with IgM-nephropathy. Am J Nephrol 9:124-128
24. Border WA (1988) Distinguishing minimal-change disease from mesangial disorders. Kidney Int 34:419-434
25. Kincaid-Smith P (1975) Glomerular lesions in atrophic pyelonephritis and reflux nephropathy. Kidney Int 8 [Suppl. 4]:S81-S83
26. Rao TKS, Nicastri AD, Freidman EA (1974) Natural history of heroin-associated nephropathy. N Engl J Med 290:19-23
27. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G (1989) Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 35:1358-1370
28. Cohen AH, Sun NCJ, Shapshak P, Imagawa DT (1989) Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2:125-128
29. Habib R, Courtecuisse V, Mathieu H, Royer P (1962) Un type anatomoclinique particulier d'insuffisance rénale chronique de l'infant. L'hypoplasie oligonéphronique congénitale bilatérale. J Urol Nephrol (Paris) 68:139
30. Fogo A, Ichikawa I (1992) Glomerular growth promoter - the common channel to glomerular sclerosis. In: Mitch WE (ed) Contemporary issues in nephrology: the progressive nature of renal disease, 2 edn. Churchill Livingstone, New York, pp 23-54
31. Aschinberg LC, Koskimies O, Bernstein J, Nash M, Edelmann CM Jr, Spitzer A (1978) The influence of age on the response to renal parencymal loss. Yale J Biol Med 51:341-345
32. O'Donnell MP, Kasiske BL, Raij L, Keane WF (1985) Age is a determinant of the glomerular morphologic and functional responses to chronic nephron loss. J Lab Clin Med 106:308-313
33. Ikoma M, Yoshioka T, Ichikawa I, Fogo A (1990) Mechanism of the unique susceptibility of deep cortical glomeruli of maturing kidneys to severe focal glomerular sclerosis. Pediatr Res 28:270-276
34. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR (1991) Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058-1062
35. Chen YT, Cohen RA, Scheinman JI, Kolbeck PC, Sidbury JB (1988) Renal disease in type I glycogen storage disease. N Engl J Med 318:7-11
36. Thomson PD, Stokes CR, Barratt TM, Turner MW, Soothill JF (1976) HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood. Lancet II:765-768
37. Schnaper HW (1989) The soluble immune response suppressor pathway in nephrotic syndrome. Semin Nephrol 9:107-111
38. Takeda T, Nakagawa Y, Narita I, Kimura H, Kutsuwada T, Arakawa M (1995) Identification and characterization of specifically expressed genes in mononuclear cells from patients with glomerulosclerosis (abstract). J Am Soc Nephrol 6:854
39. Tanaka R, Sugihara K, Tatematsu A, Fogo A (1995) Internephron heterogeneity of growth factors and sclerosis - modulation of platelet derived growth factor by angiotensin II. Kidney Int 47:131-139
40. Pesce CM, Striker LJ, Peten E, Elliot SJ, Striker GE (1991) Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605
41. Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG (1994) Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 4:2032-2039
42. Szabolcs MJ, Ward L, Buttyan R. D'Agati V (1994) Apoptosis elucidated by labeling for DNA fragmentation in human renal biopsies (abstract). Lab Invest 70:160A
43. Oikawa T, Kakuchi J, Fogo A (1995) Interleukin 1ß converting enzyme (ICE) is increased in association with pathological apoptosis in the sclerotic kidney (abstract). J Am Soc Nephrol 6:1026
44. Johnson RJ (1994) The glomerular response to injury: progression or resolution? Kidney Int 45:1769-1782
45. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J (1994) Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116
46. Kitamura H, Shimizu A, Masuda Y, Muroga K, Ishizaki M, Sugisaki Y, Yamanaka N (1995) Capillary regeneration during progression or recovery of glomerulonephritis (GN) (abstract). J Am Soc Nephrol 6:872
47. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I (1991) Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 40:195-202
48. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O (1995) Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169
49. Danoff TM, Chiang MY, Ortiz A, Neilson EG (1993) Transcriptional regulation of murine RANTES (MuR) in proximal tubular cells (abstract). J Am Soc Nephrol 4:599
50. Jennette JC, Marquis A, Falk RJ, Bodick N (1990) Glomerulomegaly in focal segmental glomerulosclerosis (FSGS) but not minimal change glomerulopathy (MCG) (abstract). Lab Invest 62:48A
51. Suzuki J, Yoshikawa N, Nakamura H (1994) A quantitative analysis of the glomeruli in focal segmental giomerulosclerosis. Pediatr Nephrol 8:416-419
52. Nyberg E, Bohman SO, Berg U (1994) Glomerular volume and renal function in children with different types of the nephrotic syndrome. Pediatr Nephrol 8:285-289
53. Mauer SM, Stoffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155
54. Vats AN, Basgen JM, Steffes MW, Mauer M (1994) Mean glomerular volume (GV) in minimal change nephrotic syndrome (MCNS), focal segmental glomerulosclerosis (FSGS), normal children and adults (abstract). J Am Soc Nephrol 5:797
55. Vats A, Basgen J, Steffes M, Mauer M (1994) Glomerular number in focal segmental glomerulosclerosis (FSGS) and minimal change nephrotic syndrome (MCNS) (abstract). J Am Soc Nephrol 5:797
56. Diamond JR, Kamovsky MJ (1986) Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 122:481-487
57. Fogo A, Hawkins EP, Verani R, MacDonell RC Jr, Ichikawa I (1991) Focal segmental glomerulosclerosis (FGS) in renal transplants is associated with marked glomerular hypertrophy (abstract). J Am Soc Nephrol 2:797
58. Rich AR (1957) A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100:173-186
59. Schreiner GF, Rovin BH, Lefkowith JB (1989) The anti-inflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis: the modulation of macrophage migration and eicosanoid metabolism. J Immunol 143:3192-3199
60. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R (1992) Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416
61. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA (1993) Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818
62. Ketteler M, Noble NA, Border WA (1995) Transforming growth factor-β and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 57:279-295
63. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462
64. Yoshida H, Kuriyama S, Atsumi Y, Tomonari Y, Mitarai T, Hamaguchi A, Kubo H, Kawaguchi Y, Kon V, Matsuoka K, Ichikawa I, and Sakai O. Angiotensin-I converting enzyme gene polymorphism in non-insulin dependent eiabetes mellitus: Risk for progression to chronic renal failure and mortality. Kidney Int (in press)
65. Neuringer JR, Anderson S, Brenner BM (1992) The role of systemic and intraglomerular hypertension. In: Mitch WE (ed) The progressive nature of renal disease, vol 26. Churchill Livingstone, New York, pp 1-21
66. Yoshida Y, Fogo A, Shiraga H, Glick AD, Ichikawa I (1988) Serial micropuncture analysis of single nephron function in the rat model of subtotal renal ablation. Kidney Int 33:855-867
67. Yoshida Y, Fogo A, Ichikawa I (1989) Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 35:654-660
68. Daniels BS, Hostetter TH (1990) Adverse effects of growth in the glomerular microcirculation. Am J Physiol 258:F1409-F1416
69. Dworkin LD, Levin RI, Bernstein JA, Parker M, Ullian ME, Kim Y, Feiner HD (1990) Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension. Am J Physiol 259:F598-F604
70. Nyengaard JR, Rasch R (1993) The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 36:189-194
71. Marcussen N, Nyengaard JR, Christensen S (1994) Compensatory growth of glomeruli is accomplished by an increased number of glomerular capillaries. Lab Invest 70:868-874
72. Akaoka K, White RHR, Raafat F (1995) Glomerular morphometry in childhood reflux nephropathy, emphasizing the capillary changes. Kidney Int 47:1108-1114
73. Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Rennke HG, Deen WM, Hoyer JR, Ichikawa I (1988) "Intact nephrons" as the primary origin of proteinuria in chronic renal disease: a study in the rat model of subtotal nephrectomy. J Clin Invest 82:1614-1623
74. Morelli E, Loon N, Meyer T Peters W, Myers BD (1990) Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39:76-82
75. Artero ML, Sharma R, Savin VJ, Vincenti F (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574-581
76. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurualt de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7-14
77. Sharma M, Sharma R, Gunwar S, Vincenti F, Artero M, Savin V (1992) Partial purification and characterization of a circulating protein (HFSF) that increases glomerular albumin permeability in human focal segmental glomerular sclerosis (abstract). J Am Soc Nephrol 3:751
78. Benigni A, Zoja C, Remuzzi G (1995) The renal toxicity of sustained glomerular protein traffic. Lab Invest 73:461-468
79. Eddy AA, Giachelli CM (1995) Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557
80. Thomas ME, Schreiner GF (1993) Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol 13:385-398
81. Kees-Folt D, Sadow JL, Schreiner GF (1994) Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45:1697-1709
82. Keane WF, Kasiske BL, O'Donnell MP (1988) Hyperlipidemia and the progression of renal disease. Am J Clin Nutr 7:157-160
83. Allon M, Pasque CB, Rodriguez M (1990) Acute effect of captopril and ibuprofen on proteinuria in patients with nephrosis. J Lab Clin Med 116:462-468
84. Schainnuck LI, Striker GE, Cutler RE, Benditt EP (1970) Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1:631-641
85. Baylis C, Brenner BM (1978) Mechanism of the glucocorticoid-induced increase in glomerular filtration rate. Am J Physiol 234:F166-F170
86. Fogo A, Sakai T, Berliner KTN, Ichikawa I (1991) Insidious nature of diabetic nephropathy: glomerular sclerosis can develop with normal serum creatinine. Lab Invest 64:97A
87. Besbas N, Topaloglu R, Saatci O, Bakkaloglu A (1992) Long term follow-up in children with steroid-resistant nephrotic syndrome. Clin Pediatr (Phila) 31:283-288
88. United States Renal Data System 1991 Annual Data Report (1991) ESRD in children. Am J Kidney Dis 18 [Suppl 2]:79-88
89. McEnery PT, Stablein DM, Arbus G, Tejani A (1991) Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study. N Engl J Med 326:1727-1732
90. Bakir AA, Bazilinski NG, Rhee HL, Ainis H, Dunea G (1989) Focal segmental glomerulosclerosis. A common entity in nephrotic black adults. Arch Intern Med 149:1802-1804
91. Walker R, Bailey RR, Lynn KL, Burry AF (1982) Focal glomerulosclerosis - another familial renal disease? N Z Med J 95:686-688
92. Felldin M, Norden G, Svalander C, Nyberg G (1995) Focal segmental glomerulosclerosis - familial and sporadic forms (abstract). Proceedings of the Nordic Nephrology Meeting, p. 12
93. Schulman SL, Vaniska J, Kaplan B (1995) Two populations of focal segmental glomerulosclerosis (FSGS) in children (abstract). J Am Soc Nephrol 6:432
94. Pesce C, Schmidt K, Fogo A, Okoye MI, Kim R, Striker LJ, Striker GE (1994) Glomerular size and the incidence of renal disease in African Americans and Caucasians. J Nephrol 7:355-358
95. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V (1996) Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49: 571-577
96. Fogo A, Yoshida Y, Yared A, Ichikawa I (1990) Importance of angiogenic action of aagiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38:1068-1074
97. Dileepan KN, Sharma R, Stechschulte DJ, Savin VJ (1993) Effect of superoxide exposure on albumin permeability of isolated rat glomeruli. J Lab Clin Med 121:797-804
98. Diamond JR, Bonventre JV, Karnovsky MJ (1986) A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29:478-483
99. Williams JD, Coles GA (1994) Proteinuria - a direct cause of renal morbidity? Kidney Int 45:43-50
100. D'Amico G, Ferrario F, Rastaldi MP (1995) Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 26:124-132
101. Praga M, Hemandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL (1992) Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20:240-248
102. Primack WA, Schulman SL, Kaplan BS (1994) An analysis of the approach to management of childhood nephrotic syndrome by pediatric nephrologists. Am J Kidney Dis 23:524-527
103. Cattran DC, Greenwood C, Ritchie S (1994) Long-term benefit of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254
104. Arbeitsgemeinschaft für Padiarrische Nephrologie (1988) Short versus standard prednisone therapy for initial treatment for idiopathic nephrotic syndrome in children. Lancet I:380-383
105. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Ranee P (1987) Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82:938-944
106. Brodehl J, Hoyer PF, Oemar BS, Helmchen U, Wonigeit K (1988) Cyclosporine treatment of nephrotic syndrome in children (review). Transplant Proc 20 [Suppl 4]:269-274
107. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DC (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:211-218
108. White RHR, Glasgow EF, Mills RJ (1970) Clinicopathologic study of nephrotic syndrome in childhood. Lancet I:1299-1302
109. Habib R, Kleinknecht C (1971) The primary nephrotic syndrome of childhood. Pathol Annu 6:417-474
110. Hyman LR, Burkholder PM (1974) Focal sclerosing glomerulonephropathy with hylanosis. J Pediatr 84:217-225
111. Nash MA, Greifer I, Olbing H, Bennet B, Spitzer A (1976) The significance of focal sclerotic lesions of glomeruli in children. J Pediatr 88:806-813
112. Morita M, White RHR, Coad NAG, Raafat F (1990) The clinical significance of the glomerular location of segmental lesion in focal segmental glomemlosclerosis. Clin Nephrol 33:211-219
113. Mongeau JG, Corneille L, Robitaille PO, O'Regan S, Pelletier M (1981) Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe? Kidney Int 20:743-746
114. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561-564
115. Arbus GS, Poucell S, Bacheyie GS, Baumal R (1982) Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. J Pediatr 101:40-45
116. Mowry J, Marik J, Cohen A, Hogg R, Sahney S, Ettenger R (1993) Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis. Transplant Proc 25:1345-1346
117. Habib R (1973) Focal glomerularsclerosis. Kidney Int 4:355-361
118. Ellis D, Kapur S, Antonovych TT, Salcedo JR, Yunis EJ (1978) Focal glomerulosclerosis in children: correlation of histology with prognosis. J Pediatr 93:762-768
119. Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 21:75-85
120. Ellis D, Buffone GJ (1981) Protein clearances and selectivity determinations in childhood nephrosis: a reappraisal. Clin Chem 27:1397-1400
121. Guasch A, Hashimoto H, Sibley RK, Deen WM, Myers BD (1991) Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis. Am J Physiol 260:F728-F737
122. Laurent J, Philippon C, Lagrue G, Laurent G, Weil B, Rostoker G (1993) Proteinuria selectivity index - prognostic value in lipoid nephrosis and related disease. Nephron 65:185-189
123. Kouhat EC, Edwards GA, Hill LL, Rosenberg HS, Hartley MW (1981) Focal glomerulosclerosis. Extent of involvement related to steroid resistance. Am J Clin Pathol 75:181-185
124. Querfeld U, Waldherr R, Scharer K (1985) The significance of focal global sclerosis in idiopathic nephrotic syndrome: long-term clinical observations. Acta Paediatr Scand 74:913-919
125. Schulman SL, Kaiser BA, Polinsky MS, Srinivasan R, Baluarter HJ (1988) Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns. J Pediatr 113:996-1001
126. Siegel NJ, Gaudio KM, Krassner LS, McDonald BM, Anderson FP, Kashgarian M (1981) Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment. Kidney Int 19:454-459
127. Holdsworth SR, Bellomo R (1984) Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit. Kidney Int 26:162-169
128. Schreiber AD, Parson J, McDermott P, Cooper RA (1975) Effects of corticosteroids on human monocyte IgG and complement receptors. J Clin Invest 56:1189-1197
129. Werb Z (1978) Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase and plasminogen activator secretion and effects on other metabolic functions. J Exp Med 147:1685-1712
130. Fujiwara Y (1984) An ultrastructural study of the effect of steroid in puromycin aminonucleoside nephrosis rats. Virchow Arch [A] 405:11-24
131. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I (1991) Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40:291-301
132. Ritz E (1994) Pathogenesis of "idiopathic" nephrotic syndrome. N Engl J Med 330:61-62
133. Yoshioka T, Kawamura T, Meyrick BO, Beckman JK, Hoover RL, Yoshida H, Ichikawa I (1994) Induction of manganese superoxide dismutase by glucocorticoids in glomerular cells. Kidney Int 45:211-219
134. Macconi D, Zanoli AF, Orisio S , Longaretti L, Magrini L, Rota S, Radice A, Pozzi C, Remuzzi G (1993) Methylprednisolone normalizes superoxide anion production by polymorphs from patients with ANCA-positive vasculitides. Kidney Int 44:215-220
135. Tsunoda Y, Iwamoto N, Shiraga H, Kawaguchi H, Ito K, Nomura K, Shimizu S, Yoshioka T (1995) Down regulation of glucocorticoid receptor expressions in young patients with steroid-resistant nephrotic syndrome (abstract). J Am Soc Nephrol 6:433
136. Brodehl J (1986) Nephrotic syndrome in children. Diagnosis and treatment. World Pediatr Child Care 1:9-18
137. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM (1990) Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4:303-307
138. International Study of Kidney Disease in Children (1982) Cyclophosphamide therapy in focal segmental glomerular sclerosis: a controlled clinical trial. Pediatr Res 16:320A
139. Arbeitsgemeinschaft für Pädiatrische Néphrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451-454
140. Travis LB, Chesney R, McEnery P, Moel D, Pennisi A, Potter D, Talwalkar YB, Wolff E (1978) Growth and glucocorticoids in children with kidney disease. Kidney Int 14:365-368
141. Lettgen B, Jeken C, Reiners C (1994) Influence of steroid medication on bone mineral density in children with nephrotic syndrome. Pediatr Nephrol 8:667-670
142. Padilla R, Brem AS (1989) Linear growth of children with nephrotic syndrome: effect of alkylating agents. Pediatrics 84:495-499
143. Korbet SM, Schwartz MM, Lewis EJ (1994) Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23:773-783
144. Lentz RD, Bergstein J, Steffes MW, Brown DR, Prem K, Michael AF, Vernier RL (1977) Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty. J Pediatr 91:385-394
145. Watson AR, Taylor J, Ranee CP, Bain J (1986) Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome; a long-term follow-up study. Fertil Steril 46:331-333
146. Bogdanovic R, Banicevic M, Cvoric A (1990) Pituitary-gonadal function in women following cyclophosphamide treatment for childhood nephrotic syndrome. Pediatr Nephrol 4:455-458
147. Callis L, Nieto J, Vila A, Rende J (1980) Chlorambucil treatment in minimal lesion nephrotic syndrome, a reappraisal of its gonadal toxicity. J Pediatr 97:653-656
148. Guesry P, Lenoir G, Broyer M (1978) Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 92:299-303
149. Lewis EJ (1988) Management of the nephrotic syndrome in adults. In: Cameron JS, Glassock RJ (eds) The nephrotic syndrome. Marcel Dekker, New York, pp 461-521
150. Baluarte HJ, Gruskin AB (1978) Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial. J Pediatr 92:295-298
151. Almeida MP, Almeida HA, Rosa FC (1994) Vincristine in steroid-resistant nephrotic syndrome. Pediatr Nephrol 8:79-80
152. Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA (1987) Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. Nephron 46:73-77
153. Mendoza SA, Tune BM (1992) Treatment of childhood nephrotic syndrome. J Am Soc Nephrol 3:889-894
154. Tejani A, Butt K, Trachtman H, Suthanthiran M, Rosenthal O, Khawar MR (1987) Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J Pediatr 111:1056-1062
155. Niaudet P (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr 125:981-986
156. Melocoton TL, Kamil ES, Cohen AH, Fine RN (1991) Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 18:583-588
157. Glassock RJ (1994) Role of cyclosporine in glomerular disease (review). Cleve Clin J Med 61:363-369
158. Walker RG, Kincaid-Smith P (1990) The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomulosclerosis) with ciclosporin. Nephron 54:117-121
159. Windom HH, Fisher M, Neale TJ (1988) Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis. N Z Med J 103:125-126
160. Hymes LC (1995) Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome. Pediatr Nephrol 9:137-139
161. Brodehl J (1991) Conventional therapy for idiopathic nephrotic syndrome in children. Cyclophosphamide for 12 weeks for those who are steroid-dependent. Clin Nephrol 35 [Suppl 1]:S8-S15
162. Cattran D, Greenwood C, Hebert L, Pohl M, Hunsicker L, Maxwell D, Kunis C (1995) Follow up results from a randomized controlled trial (RCT) of cyclosporine (T) vs placebo (C) in adults with steroid resistant idiopathic focal segmental glomerulosclerosis (SR-FSGS) (abstract). J Am Soc Nephrol 6:414
163. Cattran D, Greenwood C, Bernstein K, Hebert L, Pohl M, Maxwell D, Appel G, Hoy W, Faber M, Hegeman R for the North American Nephrotic Syndrome Sudy Group (1995) Results of a 6 month randomized controlled trial of cyclosporine (T) vs placebo (C) in adults with steroid resistant idiopathic focal segmental glomerulosclerosis (SR-FSGS) (abstract). J Am Soc Nephrol 6:415
164. Tirelli AS, Paterlini G, Ohio L, Edefonti A, Assael BM, Bettinelli A, Cavanna G, Sereni F (1993) Renal effects of cyclosporin A in children treated for idiopathic nephrotic syndrome. Acta Paediatr 82:463-468
165. Webb KI, Sargent P, Burke JR (1993) Cyclosporine therapy in steroid-dependent nephrotic syndrome. J Paediatr Child Health 29:188-191
166. Niaudet P, Broyer M (1989) Cyclosporine in the therapy of idiopathic nephrotic syndrome in children. In: Andreucci VE, Fine LG, Hatano M, Kjellstrand CM (eds) International yearbook of nephrology. Kluwer, Boston, pp 55-168
167. Burdmann EA, Young B, Andoh TF, Evans A, Alpers CE, Lindsley J, Johnson RJ, Couser W (1994) Mechanisms of cyclosporine-mduced interstitial fibrosis. Transplant Proc 26:2588-2589
168. Hunley TE, Fogo A, Iwasaki S, Kon V (1995) Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity. J Am Soc Nephrol 5:1718-1723
169. Kon V, Hunley TE, Fogo A (1995) Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation 60:89-95
170. Tufro-McReddie A, Alvarez E, Arrizurieta E, Repetto H (1992) Focal glomerulosclerosis in children: an Argentinian experience. Pediatr Nephrol 62:158-161
171. Praga M, Borstein B, Andres A, Ruilope LM, Rodicio JL (1991) Nephrotic proteinuria without hypoalbummemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis 17:330-338
172. Cochat P, Kassir A, Colon S, Glastre C, Tourniaire B, Parchoux B, Martin X, David L (1993) Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 7:50-54
173. McCauley J, Shapiro R, Ellis D, Igdal H, Tzakis A, Starzl TE (1993) Pilot trial of FK506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 8: 1286-1290
174. Guidi E, Magni M, Belgiojoso GB di, Minetti L, Bianchi G (1984) Blood pressure in patients with four different primary glomerulopathies. Clin Exp Hypertens [A] 6:1357-1366
175. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A (1994) Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537-543
176. Kon V, Fogo A, Ichikawa I (1993) Bradykinin causes selective efferent arteriolar dilation during angiotensin I convening enzyme inhibition. Kidney Int 44:545-550
177. Moorhead JF (1991) Lipids and progressive kidney disease. Kidney Int 39:S35-S40
178. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP (1991) Hyperlipidemia and progressive renal disease. Kidney Int 39:S41-S48
179. Golper TA, Illingworth R, Morris CD, Bennet WM (1989) Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria. Am J Kidney Dis 13:312-320
180. Shibasaki T, Nakano H, Matsuda H, Onno I, Matsumonot H, Misawa T, Ishimoto F, Sakai O (1993) Pravastatin administration to hyperlipidemia in patients with nephrotic syndrome. J Jpn Soc Nephrol 35:1243-1248
181. Larsen ML, Illingworth DR (1994) Drug treatment of dyslipoproteinemia (review). Med Clin North Am 78:225-245
182. Alkjaersig N, Fletcher AP, Narayanan M, Robson AM (1987) Course and resolution of the coagulopathy in nephrotic children. Kidney Int 31:772-780
183. De Mattia D, Penza R, Giordano P, Di Bitonto G, Altomare M, Del Vecchio GC, Schettini F (1991) Thromboembolic risk in children with nephrotic syndrome. Haemostasis 21:300-304
184. Purkerson ML, Hoffsten PE, Klahr S (1976) Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9:407-417
185. Homma T, Butt K, Trachtman H, Suthanthiran M, Rosenthal CJ, Khawar MR (1987) Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J Pediatr 111:1056-1062
186. Lines DR, Coleman M, Gallus A (1989) Focal glomerulosclerosis treated with heparin. Arch Dis Child 64:855-857
187. Tojo S, Marita M, Koyama A, Sano M, Suzuki H, Tsuchiya T, Tsuchida H, Yamamoto S, Shishido H (1978) Dipyridamole therapy in the nephrotic syndrome. Contrib Nephrol 9:111-127
188. Zimmerman SW (1985) Plasmapheresis and dipyridamole for recurrent focal glomerulosclerosis. Nephron 40:241-245
189. Donker AJ, Brentjens JR, Hem GK van der, Arisz L (1978) Treatment of the nephrotic syndrome with indomethacin. Nephron 22:374-381
190. Alavi N, Lianos EA, Venuto RC, Mookerjee BK, Bentzel CJ (1986) Reduction of proteinuria by indomethacin in patients with nephrotic syndrome. Am J Kidney Dis 8:397-403
191. Heeg JE, Jong PE de, Vriesendorp R, Zeeuw D de (1990) Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Am J Nephrol 10 [Suppl 1]:94-97
192. Golbetz H, Black V, Shemesh O, Myers BD (1989) Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. Am J Physiol 256:F44-F51
193. Mathew TH (1988) Recurrence of disease following renal transplantation. Am J Kidney Dis 12:85-96
194. Striegel JE, Sibley RK, Fryd DS, Mauer SM (1986) Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int 30:S44-S50
195. Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP (1991) Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 52:827-831
196. Malekzadeh MH, Ettinger RB, Uittenbogaart CH, Fine RN (1979) Focal glomerulosclerosis and renal transplantation. J Pediatr 95:249-254
197. Cameron JS (1982) Glomerulonephritis in renal transplants. Transplantation 34:237-245
198. Mathew TH (1988) Nephrotic syndrome in patients with transplanted kidneys. In: Cameron JS, Glassock RJ (eds) The nephrotic syndrome. Marcel Dekker, New York, pp 805-848
199. Artero M, Biava C, Amend W, Tomlanovich S, Vincent F (1992) Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92:375-383
200. Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2 [Suppl 3]:S258-263
201. Cheigh JS, Mauradian J, Solithan M, Tapia L, Riggio RR, Stenzel KH, Rubin AL (1983) Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 4:449-455
202. Hosenpud J, Piering WF, Garancis JC, Kauffman HM (1985) Successful second kidney transplantation in a patient with focal glomerulosclerosis. A case report (review). Am J Nephrol 5:299-304
203. Ramos EL, Tisher CC (1994) Recurrent disease in the kidney transplant. Am J Kidney Dis 24:142-154
204. Ramos EL (1991) Recurrent diseases in the renal allograft. J Am Soc Nephrol 2:109-121
205. Kashtan CE, McEnery PT, Tejani A, Stablein DM (1995) Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 9:679-684
206. Hayes JM, Steinmuller DR, Streem SB, Novick AC (1991) The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys. Transplantation 52:813-817
207. Pinto J, Lacerda G, Cameron JS, Turner DR, Bewick M, Ogg CS, and the Physicians, Pediatricians, and Pathologists of the South East Thames Renal Units (1981) Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation 32:83-89
208. Maizel SE, Sibley RK, Horstman JP, Kjellstrand CM, Simmons RL (1981) Incidence and significance of recurrent focal segmentai glomerulosclerosis in renal allograft recipients. Transplantation 32:512-516
209. Axelsen RA, Seymour AE, Mathew TH, Fisher G, Canny A, Pascoe V (1984) Recurrent focal glomerulosclerosis in renal transplants. Clin Nephrol 21:110-114
210. Ingulli E, Tejani A (1991) Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children - a single-center experience. Transplantation 51:401-405
211. Kershaw DB, Sedman AB, Kelsch RC, Bunchman TE (1994) Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide. Clin Transplant 8:546-549
212. Habib R, Antignac C, Hinglais N (1987) Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis 10:198-207
213. Voets AJ, Hoitsma AJ, Koene RAP (1986) Recurrence of nephrotic syndrome during cyclosporin treatment after renal transplantation (letter). Lancet 1:266-267
214. Pirson Y, Squifflet JP, Marbaix E, Arenas J, Oliet A, Montoyo C, Ruilope LM, Rodicio JL (1986) Recurrence of focal glomerulosclerosis despite cyclosporine treatment after renal transplantation (letter). BMJ 292:1336
215. Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T. Fogo A, Sakai T, Ichikawa I (1991) Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure. Kidney Int 40:461-469
216. Munoz J, Sanchez M, Perez-Garcia R, Anaya F, Valderrábano F (1985) Recurrent focal glomerulosclerosis in renal transplants, proteinuria relapsing following plasma exchange. Clin Nephrol 24:213-214
217. Newraan WJ, Tisher CC, McCoy RC, Gunnells JC, Krueger RP, Clapp JR, Robinson R (1976) Focal glomerular sclerosis: contrasting clinical patterns in children and adults. Medicine (Baltimore) 55:67-87
218. Feld S, Figueroa P, Cha D, Savin V, Sharma R, Sharma M, Nast C, Hirschberg R, LaPage J, Adler SG (1995) Do circulating factors contribute to proteinuria (Up) and matrix (ECM) synthesis in the native kidneys of patients with idiopathic focal sclerosis (FSGS) (abstract)? J Am Soc Nephrol 6:417
219. Savin VS (1993) Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 21:347-362
220. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M (1991) A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40:453-460
221. Halevy J, Hayslett JP 1986) Clinical features and course of focal glomerulosclerosis. In: Mitch WE, Brenner BM, Stein JH (eds) The progressive nature of renal disease. Churchill Livingstone, New York, pp 189-201
222. Broyer M, Gagnadoux MF, Guest G, Beurton D, Niaudet P, Habib R, Busson M (1987) Kidney transplantation in children: results of 383 grafts performed at Enfants Malades Hospital from 1973 to 1984. Adv Nephrol 16:307-333
223. Tejani A, Nicastri AD, Sen D, Chen CK, Phadke K, Adamson O, Butt KMH (1983) Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis. Nephron 35:225-231
224. Takeuchi A, Yoshizawa N, Kubota T, Niwa H (1989) A clinicopathologic study of focal segmental glomerulosclerosis: comparison between nephrotic and non-nephrotic focal segmentai glomerulosclerosis. Jpn J Med 28:577-584
225. Korbet SM, Schwartz MM, Lewis EJ (1986) The prognosis of focal segmental glomerulosclerosis of adulthood. Medicine (Baltimore) 65:304-311
226. Ingulli E, Tejani A (1991) Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393-397
227. Wakai S, Magil AB (1992) Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 41:428-434
228. Claris-Appiani A, Galato R, Marra G, Assael BM, Seveso M (1986) Prediction of the progression of renal failure in adult and in pediatric patients with malignant focal glomeruloscierosis. Clin Nephrol 26:87-90
229. Imbasciati E, Ponticelli C, Case N, Altieri P, Bolasco F, Mihatsch MJ, Zollinger HU (1981) Acute renal failure in idiopathic nephrotic syndrome. Nephron 28:186-191
230. Wehrmann M, Böhle A, Held H, Schumm G, Kendziora H, Pressler H (1990) Long-term prognosis of focal sclerosing glomerulonephritis: an analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33:115-122
231. Taube D, Chapman S, Brown Z, Williams DG (1981) Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome. Clin Nephrol 15:286-290
232. Waldo FB, Benfield MR, Kohaut EC (1992) Methylprednisolone treatment of patients with steroid-resistant nephrotic syndrome. Pediatr Nephrol 6:503-505
233. Sa GA, Luis JP, Mendonca E, Almeida M, Rosa FC (1996) Treatment of childhood steroid-resistant nephrotic syndrome with pulse methylprednisolone and cyclophosphamide. Pediatr Nephrol 10:250.